bioactive composite
Devicebioactive composite restoration
NCT Number: NCT07524842
The clinical performance of a bioactive composite (alkasite-based), a nanohybrid resin composite and a bulk-fill resin composite in class II restorations will be evaluated and compared. After recruiting participants with at least 3 approximal caries lesions, all restorations will be placed by a single clinician. All caries lesions will be removed before restoring. Cavities will be divided into three groups: a bioactive composite [Cention Forte Ivoclar Vivadent, Schaan, Liechtenstein], a nanohybrid resin composite [Tetric N-Ceram2 (Ivoclar Vivadent, Schaan, Liechtenstein)] and a bulk-fill resin composite [Tetric N-PowerFill2 (Ivoclar Vivadent, Schaan, Liechtenstein)], All restorative procedures will be conducted according to manufacturers' instructions. Restorations will be scored using FDI criteria after a week (baseline) 6, 12, 24, 36 and 48 months. Descriptive statistics will be performed using chi-square tests.
Trial opening soon.
Get Notified18 year–65 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
bioactive composite restoration
nanohybrid resin composite restoration
bulk-fill resin composite restoration
Time frame: two years
Two year results according to FDI criteria (scores 1-5, 1-very good, 5-poor/replace)
Hacettepe University
Other
Clinical Performance of Three Different Restorative Materials-Nanohybrid, Bulk-fill, and Alkasite-based
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00728754
Partial Edentulism, Stomatognathic Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT00723944
Partial Edentulism, Stomatognathic Diseases
Berlin, Germany
View Trial DetailsNCT00728962
Partial Edentulism, Stomatognathic Diseases
Los Angeles, California, United States
View Trial DetailsNCT00726063
Partial Edentulism, Stomatognathic Diseases
Birmingham, Alabama, United States
View Trial Details